A step in the right direction for complex generics In 2021, the FDA and EMA launched a parallel scientific advice pilot program for complex generic/hybrid drug products.

Families use the program for a wide variety of needs: respite care, developmental toys, therapies, medical expenses, specialized equipment (such as adaptive bikes) or parent educational opportunities.

The program has reduced hospital admissions by 27% and reduced overall hospital stays by 50% for medically complex children, the nurses said. Project Austin has also saved hospitals roughly $221 ...